Domantis Limited

Active03907643 Private limited company

Incorporated: 17 January 2000 (26 years)
Industry: Other research and experimental development on natural sciences and engineering (72190)
Directors: Demet Gurunlu Russ
Edinburgh Pharmaceutical Industries Limited
Glaxo Group Limited
Owned by: Glaxo Group Limited
Accounts type: Audit exemption subsidiary
Region: East of England
Address: Gsk Medicines Research Centre
Gunnels Wood Road
Stevenage
SG1 2NY

Filing status

Accounts due: 30 September 2027
Last accounts: 31 December 2025
Conf. stmt due: 24 September 2027
Last conf. stmt: 10 September 2026

Charges

Total: 1
Outstanding: 0
Part satisfied: 0
Satisfied: 1

Officers 4 active

Officer details are public data from the Companies House register.

Gurunlu Russ, Demet

Director · Appointed 25 June 2024

Also at Glaxosmithkline Intellectual Property Holdings Limited, Glaxosmithkline Intellectual Property Limited, Glaxosmithkline Intellectual Property (No.4) Limited · more companies

Turkish

Born October 1971 (55)

Whyte, Victoria Anne

Secretary · Appointed 5 January 2007

Also at Glaxosmithkline Services Unlimited, GSK PLC, Beecham Group PLC · more companies

British

Edinburgh Pharmaceutical Industries Limited

Corporate Director · Appointed 5 January 2007

Also at British Pharma Group Limited, Glaxosmithkline Services Unlimited, Beecham Group PLC · more companies

Glaxo Group Limited

Corporate Director · Appointed 5 January 2007

Also at Glaxosmithkline Services Unlimited, Beecham Group PLC, Dealcyber Limited · more companies

Officer history (27 former)

25 June 2024

Appointed Gurunlu Russ, Demet as Director

25 June 2024

Resigned Anderson, Jill Dawn as Director

4 April 2023

Appointed Anderson, Jill Dawn as Director

24 March 2023

Resigned Andries, Jerome Charles Maurice as Director

2 March 2020

Resigned Borger, James as Director

2 March 2020

Resigned Panagiotidis, Charalampos as Director

2 March 2020

Appointed Andries, Jerome Charles Maurice as Director

3 April 2019

Resigned Burns, Alan George as Director

25 February 2019

Appointed Borger, James as Director

15 February 2019

Appointed Panagiotidis, Charalampos as Director

13 February 2019

Resigned Dubianskij, Oleg as Director

31 January 2017

Appointed Dubianskij, Oleg as Director

14 December 2012

Resigned Davies, Derek as Director

3 December 2012

Appointed Burns, Alan George as Director

20 October 2010

Resigned Grist, Ashley Alexander as Director

16 August 2010

Appointed Davies, Derek as Director

26 May 2009

Appointed Grist, Ashley Alexander as Director

5 January 2007

Resigned Maini, Ravinder Nath, Sir as Director

5 January 2007

Appointed Glaxo Group Limited as Corporate Director

5 January 2007

Appointed Edinburgh Pharmaceutical Industries Limited as Corporate Director

5 January 2007

Resigned Bridges, Melvyn John as Director

5 January 2007

Resigned Reeders, Stephen Thomas, Dr as Director

5 January 2007

Resigned Connelly, Robert as Director

5 January 2007

Resigned Skaletsky, Mark as Director

5 January 2007

Resigned Winter, Gregory Paul, Sir as Director

5 January 2007

Resigned Garner, Jeffrey Scott as Director

5 January 2007

Resigned Tomlinson, Ian Michael as Director

5 January 2007

Resigned Pitchford, Nigel Aaron, Dr as Director

5 January 2007

Resigned Tomlinson, Ian Michael as Secretary

5 January 2007

Appointed Whyte, Victoria Anne as Secretary

20 September 2006

Resigned Brister, David John as Director

20 September 2006

Appointed Reeders, Stephen Thomas, Dr as Director

17 December 2004

Appointed Skaletsky, Mark as Director

19 February 2004

Appointed Pitchford, Nigel Aaron, Dr as Director

19 February 2004

Appointed Garner, Jeffrey Scott as Director

18 November 2003

Appointed Maini, Ravinder Nath, Sir as Director

24 July 2003

Appointed Bridges, Melvyn John as Director

24 July 2003

Resigned Kwik, Stephen as Director

15 May 2003

Resigned Dalrymple, Michael Alexander, Dr as Director

13 December 2001

Resigned Burr, Kenneth Edward as Secretary

13 December 2001

Appointed Tomlinson, Ian Michael as Secretary

4 April 2001

Appointed Kwik, Stephen as Director

23 February 2001

Appointed Connelly, Robert as Director

18 October 2000

Appointed Burr, Kenneth Edward as Secretary

18 October 2000

Resigned Tomlinson, Ian Michael as Secretary

19 July 2000

Appointed Dalrymple, Michael Alexander, Dr as Director

19 July 2000

Appointed Brister, David John as Director

26 May 2000

Appointed Winter, Gregory Paul, Sir as Director

5 April 2000

Resigned Nicholson, Kim as Director

5 April 2000

Appointed Tomlinson, Ian Michael as Director

5 April 2000

Resigned Diep, Angela as Secretary

5 April 2000

Appointed Tomlinson, Ian Michael as Secretary

24 January 2000

Appointed Diep, Angela as Secretary

24 January 2000

Appointed Nicholson, Kim as Director

24 January 2000

Resigned Hallmark Secretaries Limited as Corporate Nominee Secretary

24 January 2000

Resigned Hallmark Registrars Limited as Corporate Nominee Director

17 January 2000

Appointed Hallmark Secretaries Limited as Corporate Nominee Secretary

17 January 2000

Appointed Hallmark Registrars Limited as Corporate Nominee Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Glaxo Group Limited

Corporate entity · Notified 6 April 2016

Owns 75–100% of shares

Holds 75–100% of voting rights

Right to appoint and remove directors

Private Limited Company

Reg. no. 305979

Filings

Recent filings only. See the full history on Companies House

Date	Description	Made Up To
10 September 2026	Confirmation statement with no updates	10 September 2026
24 May 2026	Accounts filing
24 May 2026	Audit exemption subsidiary accounts	31 December 2025
24 May 2026	Other filing
24 May 2026	Other filing